Compare Research Peptides

Select 2 peptides to compare benefits, dosage, administration routes, mechanisms, and side effect profiles side by side.

Peptide 1

Peptide 2

	Semaglutide Ozempic Sign up to track	AOD-9604 Advanced Obesity Drug Sign up to track
Category	Metabolic & Weight Loss	Metabolic & Weight Loss
Key Benefits	•Significant weight loss (average 15-20% body weight) •Improves glycemic control in diabetes •Reduces appetite and food cravings •Cardiovascular benefits +2 more	•Targets fat metabolism •Promotes lipolysis •No effects on blood sugar •No impact on insulin +2 more
Dosage	0.25-2.4 mg mg	250-500 mcg mcg
Frequency	Once weekly	Daily
Administration	Subcutaneous	Subcutaneous
Mechanism	Semaglutide is a GLP-1 receptor agonist that mimics the incretin hormone GLP-1. It is FDA-approved for type 2 diabetes management (Ozempic) and chronic weight management (Wegovy). It works by increasing insulin secretion, decreasing glucagon secretion, and slowing gastric emptying.	AOD-9604 is a modified fragment of growth hormone that specifically targets fat metabolism without affecting blood sugar. It promotes lipolysis and has no effects on insulin or glucose.
Side Effects / Risks	Not specified	Not specified
Research Status	FDA-approved for diabetes (Ozempic) and weight management (Wegovy)	Research compound